论文部分内容阅读
医院制剂是本着为医院服务的原则,结合临床,生产疗效确切和质量可靠的制剂。为规范药品价格,国家发展计划委员会于2001年3月下发了《国家计委关于印发药品政府定价办法的通知》,制定了《药品政府定价办法》,对医院制剂的价格明确了定价原则,要求各级医院按此执行,其中5％的制剂利润率是医院制剂新的核价方案(简称核价方案)的核心。但是医院在执行核价方案中却存在较大难度:一方面,按此执行,制剂成本难以收回(尤其是中药制剂),医院制剂将难以维持;另一方面,不按此方案执行,有违国家药价政策。究竟难在何处?如何解决?则是当前需要思考的问题。
Hospital preparations are based on the principle of serving the hospital, combined with clinical, production of reliable and reliable preparations. In order to standardize the prices of medicines, the National Development Planning Commission issued the “Notice of the State Development Planning Commission on Printing and Distributing the Governmental Drug Pricing Measures” in March 2001, formulated the “Medicine Government Pricing Measures,” and clarified pricing principles for hospital formulation prices. Hospitals at all levels are required to perform this procedure, of which 5% of the formulation’s profit margin is the core of the new nuclear pricing plan for hospital preparations (referred to as the nuclear pricing plan). However, hospitals have great difficulty in implementing nuclear pricing programs: On the one hand, according to this implementation, the cost of preparations is difficult to recover (especially Chinese medicine preparations), and hospital preparations will be difficult to maintain; on the other hand, if this plan is not implemented, it will be against National drug price policy. Where is the difficulty and how to solve? It is a question that needs to be considered.